More recently, protective antiviral function of human CD8+ T cells specific for an hCMV UL83/pp65-derived peptide was also shown in an HLA-A2 transgenic mouse model upon challenge infection with a “humanized” mCMV recombinant expressing the hCMV epitope (43). This evidence concerns the gene CD8A and infection.